EUVIMEDEUVIMED entdecken
Crossref

18F-FAPI PET/CT for Early Detection and Severity Assessment of Intestinal Fibrosis in a Mouse Model

Weicheng Zhou, Jiantao Ran, Xinyue Hu, Chaoqun Lv, Jianping You, Duo Sun, Leiyue Chen, Yi Tang, Hongqing Li, Daoxi Hu, Kaijun Liu, Dongfeng Chen und 1 weitere

Inflammatory Bowel Diseases · 07.07.2025 · 31 (7) · 2019-2026

DOI: 10.1093/ibd/izaf086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 09.05.2025. Verfasst von Weicheng Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorine Radioisotopes, Membrane Proteins, Intestines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Chongqing Science and Health Joint Medical Research Project-Young and Middle-aged High-level Talent Project, Natural Science Foundation of Chongqing, Science and Technology Innovation Ability Enhancement Project of Army Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate the feasibility of using 18F-fibroblast activation protein (FAP) inhibitor positron emission tomography/computed tomography (18F-FAPI PET/CT) to detect intestinal fibrosis in its early stages and identify its severity in a mouse model.

Methods

A dextran sulfate sodium (DSS)-induced mouse model of intestinal fibrosis was established. To detect pro-inflammatory cytokines and histopathology, blood and intestinal lesion samples were collected after 18F-FAPI PET/CT scanning (3.7 MBq/mice) at 3, 6, 9, and 12 weeks post-initial exposure to DSS. Correlation and diagnostic efficacy were explored between 18F-FAPI uptake and FAP expression or fibrosis score in early, late, and entire stages of intestinal fibrosis.

Results

18F-FAPI uptake was positively correlated with FAP expression throughout entire stages of intestinal fibrosis (r = 0.90). However, a weak correlation between 18F-FAPI uptake and fibrosis score (r = 0.49), and moderate diagnostic performance of 18F-FAPI PET for fibrotic severity (area under the receiver-operating characteristic curve [AUC] = 0.79) were found throughout the entire stages. Interestingly, in the early stages, 18F-FAPI PET effectively distinguished the degree of intestinal fibrosis (AUC = 0.95), and was strongly correlated with fibrosis score (r = 0.89). In the late stages, the diagnostic efficacy (AUC = 0.46) and correlation (r = −0.20) drastically decreased.

Conclusions

As Crohn’s disease (CD) with intestinal fibrosis progresses, 18F-FAPI uptake is high in the early stages and then gradually decreases. Activated fibroblasts appear more frequently in the early stages of intestinal fibrosis indicates that 18F-FAPI PET has a great potential for early identification of intestinal fibrosis and provides new insights into treatment decision-making in CD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorine RadioisotopesMembrane ProteinsIntestinesSerine EndopeptidasesColitisGelatinasesAnimalsMiceFibrosisDisease Models, AnimalSeverity of Illness IndexDextran SulfateEarly DiagnosisMaleMice, Inbred C57BLFemaleRadiopharmaceuticalsEndopeptidasesFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

18F-fibroblast activation protein inhibitorCrohn’s diseasefibrosismouse model of intestinal fibrosispositron emission tomography

Substanzen

Dextran SulfateFluorine RadioisotopesMembrane ProteinsSerine EndopeptidasesRadiopharmaceuticalsGelatinasesEndopeptidasesFibroblast Activation Protein Alpha

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing, China.
  • Department of Radiology, General Hospital of Tibet Military Area Command, Tibet, China.
  • Department of Gastroenterology, Daping Hospital, Army Medical University, Chongqing, China.
  • Department of Infectious Diseases, Southwest Hospital, Army Medical University, Chongqing, China.
  • Department of Medical Imaging, 32268 Unit, Dali, Yunnan, China.
  • Chongqing Clinical Research Center for Imaging and Nuclear Medicine, Chongqing, China.

ORCID-Profile: Xiao Chen

Förderung

  • Chongqing Science and Health Joint Medical Research Project-Young and Middle-aged High-level Talent Project
  • Natural Science Foundation of Chongqing
  • Science and Technology Innovation Ability Enhancement Project of Army Medical University
  • Chongqing Clinical Research Centre of Imaging and Nuclear Medicine

Zitieren

APA

Zhou, W., Ran, J., Hu, X., Lv, C., You, J., Sun, D., Chen, L., Tang, Y., Li, H., Hu, D., Liu, K., Chen, D., & Chen, X. (2025). 18F-FAPI PET/CT for Early Detection and Severity Assessment of Intestinal Fibrosis in a Mouse Model. Inflammatory Bowel Diseases, 31(7), 2019-2026. https://doi.org/10.1093/ibd/izaf086

Vancouver

Zhou W, Ran J, Hu X, Lv C, You J, Sun D, et al. 18F-FAPI PET/CT for Early Detection and Severity Assessment of Intestinal Fibrosis in a Mouse Model. Inflammatory Bowel Diseases. 2025;31(7):2019-2026. doi:10.1093/ibd/izaf086

BibTeX
@article{Zhou2025,
  author = {Zhou, Weicheng and Ran, Jiantao and Hu, Xinyue and Lv, Chaoqun and You, Jianping and Sun, Duo and Chen, Leiyue and Tang, Yi and Li, Hongqing and Hu, Daoxi and Liu, Kaijun and Chen, Dongfeng and Chen, Xiao},
  title = {18F-FAPI PET/CT for Early Detection and Severity Assessment of Intestinal Fibrosis in a Mouse Model},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  volume = {31},
  number = {7},
  pages = {2019--2026},
  doi = {10.1093/ibd/izaf086}
}
Kostenlos starten →